Sun, Dec 28, 2014, 1:48 PM EST - U.S. Markets closed

Recent

% | $
Quotes you view appear here for quick access.

diaDexus, Inc. Message Board

  • ryan.glaspell ryan.glaspell Aug 1, 2013 4:09 PM Flag

    how does GSK trial data affect ddxs

    What's the connection with the ongoing GSK trials and ddxs? As I understand ddxs has the PLAC test which may have been used in the GSK trials, but how would a positive outcome for GSK impact ddxs since they are only a diagnostic lab company with no stake in the gsk compound being tested that I can find.

    I've been long on ddxs and bought when they were Vaxgen and haven't been paying attention until these past couple weeks so apologies for not being current.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • "but how would a positive outcome for GSK impact ddxs since they are only a diagnostic lab company ."

      Ok, right now this diagnostic company has a test that has no solution. It is like having a test for prostate cancer and no treatment for prostate cancer. Like having a test for the flue and no medication for the flu. What is the urgent motivation to have the test done?

      If darapladib works, then there is a real need for this test. Visualize two years from now and no Dara and maybe ddxs has 30 mil in revenue. Viz two years from now and Dara on the verge of approval and ddxs looking at potential 200 mil revenue. Does that help visualize the difference?

      • 1 Reply to mgs1066
      • jwilbanks@bellsouth.net jwilbanks Aug 2, 2013 4:12 PM Flag

        Well that is not true.There is a solution. Statins lower Lp-pla2. So the physician needs to know if the patient is presenting with an additional risk factor that would be hidden otherwise without the PLAC Test. The solution is to increase the dosage. It may also motivate prescribing statins that wouldn't have been prescribed otherwise. The hope for darapladib is to take statin type therapy to a new level.

        Sentiment: Strong Buy

    • if GSK Darapladib trials show results then ddxs sells a lot more tests

 
DDXS
0.51+0.07(+15.91%)Dec 26 3:59 PMEST

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.